J-Star (NASDAQ:YMAT) Stock Falls 4.3% – What’s Next?

Shares of J-Star Holding Co., Ltd (NASDAQ:YMAT) traded down 4.3% during mid-day trading on Tuesday. The company traded as low as $1.32 and last traded at $1.32. Approximately 21,485 shares were traded during mid-day trading, a decline of 99% from the average daily volume of 1,900,074 shares. The stock had previously closed at $1.38.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on YMAT. Wall Street Zen upgraded J-Star to a “hold” rating in a report on Saturday, June 27th. Weiss Ratings lowered J-Star from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Thursday, July 9th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company presently has an average rating of “Sell”.

J-Star Trading Up 11.7%

The stock’s 50-day simple moving average is $1.87 and its 200 day simple moving average is $2.39.

J-Star Company Profile

J-Star Holding Co, Ltd. is a pharmaceutical research and development services company that supports pharmaceutical and biotechnology businesses throughout the drug-development process. Through its operating subsidiaries, the company provides contract development services designed to help clients advance drug candidates from early development through clinical manufacturing.

J-Star’s services include preformulation studies, formulation development, analytical method development and validation, stability testing, and the production of clinical trial materials.